Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).
AP Maggioni, MG Franzosi, ML Farina, E Santoro… - British Medical …, 1991 - bmj.com
OBJECTIVES--To describe the epidemiology of cerebrovascular events in patients given or
not given fibrinolytic treatment and to assess the prognostic implications and risk factors …
not given fibrinolytic treatment and to assess the prognostic implications and risk factors …
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the …
G Giussani, G Enia, E Bianchi, O Mecarelli, E Beghi… - Epilepsy & Behavior, 2020 - Elsevier
Purpose The purpose of this study was to assess the priorities of patients with epilepsy and
caring physicians and the correspondence between these priorities. Methods In this …
caring physicians and the correspondence between these priorities. Methods In this …
[HTML][HTML] Integrated imaginative distention therapy to cope with fatigue. DIMMI SI study: the first randomized controlled trial in multiple sclerosis
A Sgoifo, A Bignamini, L La Mantia, MG Celani… - Neurology and …, 2017 - Springer
Introduction Fatigue is a frequent, disabling, and difficult to treat symptom in neurological
disease and in other stress-related conditions; Integrated Imaginative Distention (IID) is a …
disease and in other stress-related conditions; Integrated Imaginative Distention (IID) is a …
The management of epilepsy in clinical practice: do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the …
G Enia, G Giussani, E Bianchi, O Mecarelli, E Beghi… - Epilepsy & Behavior, 2021 - Elsevier
Objective The objective of this study was to assess the priorities of patients with epilepsy and
their caring physicians with reference to the timing and severity of the disease. Methods This …
their caring physicians with reference to the timing and severity of the disease. Methods This …
Is the 'liberation procedure'for multiple sclerosis really liberating?
GJ Hankey, P Sandercock, TA Cantisani… - Journal of Neurology …, 2014 - jnnp.bmj.com
Multiple sclerosis (MS) is an inflammatory disease, which is immune-mediated, and
responds to immune-modulating therapies. However, it is uncertain what antigen, or …
responds to immune-modulating therapies. However, it is uncertain what antigen, or …